The European Commission and most EU states recently signed a huge contract with US pharmaceutical firm Gilead for its anti-corona drug Remdesivir.
But the World Health Organisation (WHO) says there is no evidence the medicine works.
The price was sky high - 420 times what it costs to produce the drug.
And there is little transparency for the EU taxpayer on how the Gilead deal came about or how much money might have been wasted.
The WHO recently said that there was n...
Enjoy access to all articles and 25 years of archives, comment and gift articles. Become a member for as low as €1,75 per week.
Already a member? LoginThis article is part of the investigation #BehindThePledge given financial support from Journalismfund.eu and IJ4EU. Lise Barnéoud, Lucien Hordijk, Hristio Boytchev, Ludovica Jona, and Priti Patnaik also contributed reporting
This article is part of the investigation #BehindThePledge given financial support from Journalismfund.eu and IJ4EU. Lise Barnéoud, Lucien Hordijk, Hristio Boytchev, Ludovica Jona, and Priti Patnaik also contributed reporting